Profiel
Michael A.
Byrne is Chief Financial Officer and Corporate Secretary of Viventia Biotech, Inc. Prior to joining Viventia, he was Chief Financial Officer of Hyal Pharmaceuticals, Inc. Mr. Byrne has over 20 years of executive experience in the biotech and pharmaceutical sector.
Actieve functies van Michael A. Byrne
| Bedrijven | Functie | Begin |
|---|---|---|
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Financieel Directeur/CFO | 01-01-2000 |
Eerdere bekende functies van Michael A. Byrne
| Bedrijven | Functie | Einde |
|---|---|---|
| Hyal Pharmaceutical Corp. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
| Hyal Pharmaceutical Corp. | Health Technology |
